Mumbai-based longevity and preventive healthcare startup Vytalyou has raised ₹8-10 crore in growth funding at a valuation of around ₹33 crore as it prepares to expand its operations in Mumbai and enter other major Indian cities in 2027.
The funding was secured in August 2026 from Chetan Jain of Pharma Dose and Ratan Jain of Venus Industries. The company plans to use the capital to strengthen its healthcare network and support its next phase of expansion.
Vytalyou currently operates a centre in Powai and is establishing additional centres in Juhu and Worli. Once operational, the locations will give the startup a three-centre network across Mumbai.
Founded by molecular oncologist Dr Chirantan Bose and radiologist Dr Preetesh Bhandari, Vytalyou was incorporated in September 2025. Its healthcare model combines diagnostic assessments with preventive interventions aimed at identifying potential health risks at an early stage.
The company’s Predictive Longevity Evaluation includes blood tests, ultrasound imaging, body-composition assessment and cardiovascular evaluation.
Vytalyou also provides interventions such as hyperbaric oxygen therapy, cryotherapy, photobiomodulation and regenerative therapies. The startup plans to use its Mumbai expansion as a foundation for entering additional major Indian markets from 2027.
